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Abstract 21 
To examine the impact of the second legal ban on synthetic cannabinoids (SCs) in the UK in 22 
February 2013, we surveyed the UK legal high market just before and after the change in 23 
legislation, looking for new SCs. The technique gas chromatography – mass spectrometry in 24 
electron ionization mode, most widely applied for analysis, was found to be insufficient for the 25 
identification of several SCs, and therefore liquid chromatography – high resolution-mass 26 
spectrometry (LC–HR-MS) was required. LC–HR-MS(/MS) measurements of the protonated 27 
molecule and product ions allowed the detection of up to 27 compounds as the third generation 28 
SCs in the samples analysed as part of this study, including two unknown compounds that were 29 
tentatively identified as F2201 and dealkyl-SDB006. Our results showed that banned 30 
compounds were removed from the market on the day when the ban was in place, and were 31 
replaced by other SCs immediately after the ban. In only one occasion, a banned compound 32 
(UR-144) was detected after the date when the new legislation came into place. It is also 33 
noteworthy that regardless of the change in legislation, new compounds continued to enter the 34 
market. Product ion spectral information on the third generation SCs at different collision 35 
energies given in this paper will be of help for forensic and clinical laboratories and will 36 
facilitate the detection and identification of new SCs by laboratories of control. This 37 
information is very valuable for law enforcement and policymakers and will be of help in future 38 
prevention programs.  39 
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Introduction 45 
 46 
Synthetic cannabinoids (SCs) have been introduced as drugs of abuse over the past years as a 47 
legal alternative to cannabis. They are mainly being sold mixed with herbal substances, but can 48 
also be bought in resin-like material, as powder, and in liquid e-cigarette refills. The existence 49 
of synthetic cannabinoid receptor agonists in the abuse market was first reported in 2009 by 50 
Japanese and German researchers [1-3]. In the UK, the first generation of SCs were banned in 51 
2009. The rise of new compounds has made it more and more difficult for toxicologists to keep 52 
up to date with standard analytical techniques and consequently has put users at risk when 53 
abusing these substances. In addition, users often take new substances unknowingly, because 54 
branded products change their ingredients over time and, in particular, when new legislation is 55 
put into place that bans existing SCs.  56 
Analysis of street samples containing SCs has been undertaken by mass spectrometry 57 
(MS), coupled to either gas chromatography (GC) or liquid chromatography (LC) [4-8]. GC–58 
MS has the advantage of the use of libraries under electron ionization (EI) conditions, making 59 
it possible to tentatively identify a substance when no reference standard is available in the 60 
laboratory. However, there is little possibility of identifying SCs by match in standardized GC– 61 
EI-MS libraries when such compound has not been previously reported. In this study, high-62 
resolution-mass spectrometry (HR-MS) has resulted in a valuable screening tool because it 63 
provides sensitive full spectrum MS data with high mass resolution and mass accuracy [9-11]. 64 
The information provided has made the tentative identification of the compounds detected 65 
feasible, with high degree of reliability, even without the use of reference standards. 66 
New SCs often share a common structure made out of four basic parts: a hydrophobic 67 
chain, an aromatic ring structure, a linker and a hydrophobic end-group. This common structure 68 
makes it easier to market new compounds, because these parts are interchangeable; the 69 
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European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) reported 30 new SCs 70 
in 2014, making them the second most abundant group among the new psychoactive substances 71 
(NPS) reported in Europe [12]. In February 2013, a new ban came into place in the UK. It banned 72 
the so-called second generation of synthetic cannabinoid receptor agonists [13]. This legislation 73 
banned five substances and also, contained a generic ban on compounds, being described as 74 
“structurally derived from” 14 different compounds.  75 
In this work, the effect of the 2013 ban on the UK market has been assessed. For this 76 
purpose, 188 products were acquired in different periods, before and after the ban. The new 77 
synthetic cannabinoids that emerged have been analysed by both GC– EI-MS and LC–HR-MS 78 
with a hybrid quadrupole time-of-flight (QTOF) analyser. In many cases, GC–MS analysis was 79 
insufficient to reach the unequivocal identity of the compound, and therefore LC–HR-MS was 80 
required for identification. The different compounds identified before and after the ban are 81 
discussed, and accurate-mass spectral information of the third generation SCs using different 82 
collision energies, useful for future analysis by control laboratories, is given. 83 
  84 
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Material and methods  85 
 86 
Reagents and Chemicals  87 
High-performance liquid chromatography (HPLC)-grade water was obtained by purifying 88 
demineralised water in a Milli-Q plus system from Millipore (Bedford, MA, USA); HPLC-89 
grade methanol (MeOH), formic acid (HCOOH) and sodium hydroxide (NaOH > 99%) were 90 
acquired from Scharlau (Barcelona, Spain); leucine encephalin, methyl-t-butyl ether, quinoline 91 
and tripelenamine from Sigma-Aldrich (St. Louis, MO, USA); reference standards of SCs from 92 
Cayman Chemical (Ann Arbor, MI, USA), which has been dissolved in methanol at a 93 
concentration of 1 mg/mL.  94 
Samples 95 
Three periods in the sampling campaign can be distinguished: 1) December 1st, 2012 – 96 
February 26th, 2013, the date when the new ban in the UK came into place, 49 samples were 97 
bought just before the new legislation. 2) February 26th, 2013 – June 30th, 2013, 54 samples 98 
were acquired immediately after the ban was in place. Samples from these first two sampling 99 
campaigns were bought from websites and head-shops or acquired from police authorities. All 100 
samples were powders or herbal material sold as smoking mixtures. 3) July 1st, 2013 – January 101 
31st,  2015, 85 samples were bought from the Internet regardless of the description. Among 102 
these samples were powders, herbal mixtures, one resin-like sample, and liquid e-cigarette 103 
refills, which we subject to detailed analysis by LC–QTOF-MS(/MS).  104 
Sample preparation 105 
Approximately 1 mg of powder was dissolved in 1 mL of methanol in a 1.5 mL polypropylene 106 
tube. Solutions were then vortexed for 1 min or subjected to ultrasonic-assisted extraction for 107 
15 min, and afterwards centrifuged at 8,000 rpm (6,030 g) for 5 min. For herbal mixtures, 108 
approximately 50 mg was mixed in 1 mL of methanol and vortexed for 30 min and centrifuged 109 
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at 8,000 rpm (6,030 g) for 1 min. For LC–HR-MS, an aliquot of 100 μL of the methanol extract 110 
was ten-fold diluted with water. For GC–MS analysis, a 10µL aliquot of the supernatant was 111 
diluted with 1 mL of methyl-t-butyl ether, containing 100 μg/mL quinoline and tripelenamine. 112 
Instrumentation 113 
LC–QTOF-MS(/MS) analyses were performed using an Acquity Ultra-Performance Liquid 114 
Chromatography UPLC system (Waters, Milford, MA, USA), which was interfaced to a hybrid 115 
quadrupole-orthogonal acceleration-TOF mass spectrometer (QTOF XEVO G2, Waters 116 
Micromass, Manchester, UK), using an orthogonal Z-spray-ESI interface operating in positive 117 
ion mode. The chromatographic separation was performed using an Acquity UPLC BEH C18 118 
analytical column (100 × 2.1 mm with 1.7 µm particle size; Waters). The column temperature 119 
was set to 40 ºC. The mobile phases used were A = H2O and B = MeOH, both with 0.01% 120 
HCOOH, at a flow rate of 300 µL/min [more details in supplementary material (SM) and [7]].  121 
GC–MS analyses were done using an Agilent 7890A GC with 5975C VL MSD 122 
(Agilent, Santa Clara, CA, USA) equipped with a split-splitless injector and an HP5-MS 123 
column (30 m length, 0.25 mm internal diameter, 0.25 μm film thickness) and running on 124 
Agilent ChemStation. 1 μL was injected using 5:1 split ratio. The column was held at 80°C for 125 
4 min and then ramped up at 40°C/min to 290°C and held to a total run time of 40 min. A mass 126 
range of m/z 40 to 400 was scanned with scan-time 0.25 sec.   127 
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Results and discussion 128 
LC–QTOF-MS(/MS) analysis of synthetic cannabinoids  129 
In total, 27 new cannabinoids as the 3rd generation SCs were detected for the first time in 130 
products sold on the UK market during the period just before and after the new ban came into 131 
place (December 1st, 2012– January 31st, 2015). Analyses were first performed by GC– EI-MS. 132 
It allowed several cannabinoids to be confirmed by the use of reference standards or tentatively 133 
identified by comparison with the GC–MS spectra included in Cayman Chemical Web page. 134 
The same samples were also analyzed by LC–QTOF-MS(/MS) in order to gain more 135 
confidence in the tentatively identified compounds and to study the fragmentation pathways of 136 
these new cannabinoids. Data given in this paper refers only to LC–QTOF-MS(/MS) accurate-137 
mass analysis, because this is the most relevant and new information considered of interest for 138 
the readers.  139 
Making use of LC–QTOF-MS(/MS), the sample extracts were injected in full-140 
acquisition mode working under MSE mode, acquiring the low and high collision energy 141 
spectra during the same injection[7]. Narrow-window extracted ion chromatograms were then 142 
obtained (±100 ppm mass window) at the theoretical mass of the expected protonated 143 
molecules. In all cases, mass errors obtained were lower than 5 ppm for the protonated 144 
molecule. The sodium and potassium adducts were also commonly found. In a second step, 145 
MS/MS experiments were performed in an additional injection, obtaining the accurate-mass 146 
product ion spectra after isolation of the precursor ion selected taking into account the structure 147 
of the cannabinoids. MS/MS experiments were much useful to justify the product ions obtained 148 
and to propose the fragmentation pathway of the compounds. Variation in the amount of SC 149 
present was not tested, as analysis was purely qualitative.  150 
Below, our results are briefly commented, emphasizing the major product ions 151 
observed. The exact masses, as shown in Tables 1-5, were used for the discussion of the product 152 
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ions observed and to facilitate the reading. Furthermore, to help the discussion on the chemical 153 
structures of cannabinoids identified, the compounds were classified in different groups 154 
considering their fragmentation pattern (Fig. 1). For those interested in more details regarding 155 
fragmentation, we recommend reading the information given in the supplementary material 156 
(SM). Figures included in SM (Figures S.1-S.25) show the accurate/experimental masses 157 
provided by LC–QTOF-MS(/MS). 158 
 159 
Cannabinoids containing an adamantyl group linked by an amide and SDB-006 160 
This group of cannabinoids includes four compounds: APICA, 5F-APICA, APINACA and 5F-161 
APINACA, all of which have an adamantyl group linked to the core by an amide bond. The 162 
core can be an indazole (APINACA and 5F-APINACA) or indole (APICA and 5F-APICA) 163 
and the tail a pentyl (APINACA and APICA) or a 5-fluoropentyl (5F-APICA and 5F-164 
APINACA) chain (Fig. 1).  165 
In all four compounds identified, the most abundant product ion at 30 eV corresponded 166 
to the adamantyl group (ion C, m/z 135.1174, C10H15) (Fig. 2a). Table 1 shows the product ions 167 
as well as the corresponding elemental compositions for all cannabinoids included in this 168 
group. Regarding SDB-006 (m/z 321.1967), the product ion resulting from the breaking of the 169 
central amide (m/z 214.1232) and that corresponding to the pentyl indole group (m/z 188.1439) 170 
are the most abundant ones (Fig. 2b; Table 1). LC–QTOF-MS(/MS)spectra at different 171 
collision energies for all cannabinoids in this section are included in SM (Figs. S.1-S.5). 172 
 173 
Cannabinoids with a quinolinyl ester, NM-2201 and 5F-MN-18 174 
Four cannabinoids belong to this group of compounds containing a quinolinyl ester: PB-22, 175 
5F-PB-22, BB-22 and 5F-NPB-22 (Table 2). In addition, two related compounds were also 176 
identified and are discussed here. NM-2201 is structurally similar to these cannabinoids; the 177 
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only difference is the naphthalene group instead of a quinolinyl group. 5F-MN-18, which is 178 
closely related to NM-2201, has an amide linkage. This resulted in a similar fragmentation 179 
pattern. The compound FUB-PB-22 also contained a quinolinyl ester; however it will be 180 
discussed below as a cannabinoid with a para-fluorotoluene chain because the mass spectra 181 
were quite similar to other cannabinoids containing this moiety.  182 
For PB-22, 5F-PB-22, BB-22, 5F-NPB-22 and NM-2201, the main product ion (B) was 183 
formed by cleavage of the ester bond (Table 2; Fig. 3). Another important product ion (E) was 184 
related to presence of an indole or indazole in the structure. For indole-based structures, PB-185 
22, 5F-PB-22, BB-22 and NM-2201, ion E at m/z 144.0449 (C9H6NO) was observed, whereas 186 
for indazole-based structures and as 5F-NPB-22 and 5F-MN-18, the product ions E 187 
corresponded to m/z 145.0402 (C8H5N2O). Additionally, for 5F-NPB-22 and 5F-MN-18, the 188 
m/z 213.1028 (ion C) was observed, corresponding to the loss of hydrogen fluoride (HF) from 189 
m/z 233 (Figs. S.6-S.11). 190 
 191 
Cannabinoids with a branched end group 192 
Most cannabinoids have a ring structure as end group (naphthalene, quilolinyl, adamantyl, etc.), 193 
but nine new cannabinoids from this study have a branched side chain instead: ADB-PINACA, 194 
AB-PINACA, 5F-AB-PINACA, 5F-Cumyl-PINACA, AB-CHMINACA, MDMB-CHMICA, 195 
and 5F-AMB as well as AB-FUBINACA and ADB-FUBINACA (Fig. 1). The latter two 196 
contain a para-fluorotoluene chain and will be discussed in the next section. 197 
The most prominent product ion (ion D) in all spectra was the result of the cleavage of 198 
the central amide bond (Table 3; Fig. 4). The m/z 145.0398 (G) was also abundant in all spectra 199 
(C8H5N2O), and resulted from the carbonyl-indazole group (except m/z 144.0441 for MDMB-200 
CHMINACA due to the indole group, C9H6NO) after double cleavage at the central amide 201 
bond and at the root of the pentyl or 5-fluoropentyl side chain. (Figs. S.12-S.18). 202 
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 203 
Cannabinoids with a para-fluorotoluene chain 204 
AB-FUBINACA, ADB-FUBINACA and FUB-PB-22 all have a para-fluorotoluene side chain 205 
(Figs. 1, 5) and shared common fragmentation pathways. At higher collision energies, where 206 
fragmentation is promoted, these three compounds showed two abundant product ions. The 207 
first (m/z 253.0777) was the result of the cleavage of the central amide bond (ion D), for AB-208 
FUBINACA and ADB-FUBINACA, or of the ester (m/z 252.0825) for FUB-PB-22. The 209 
second, at m/z 109.0454 (ion E, C7H6F), was due to the presence of the para-fluorotoluene side 210 
chain (Table 4; Figs. S.19-S.21). 211 
 212 
Cannabinoids with two chromatographic peaks 213 
Two chromatographic peaks were observed in the LC–QTOF-MS chromatograms at the 214 
expected m/z for five compounds, concretely AB-FUBINACA, ADB-PINACA,AB-PINACA, 215 
5F-AB-PINACA, and AB-CHMINACA (Table 3; Fig. 5a). For these compounds, the two 216 
chromatographic peaks presented different fragmentation, being all compatible with the 217 
structure of the corresponding cannabinoid. All of them possess a terminal amino group and an 218 
enantiomeric carbon at the linker part. Moreover, some common product ions were also 219 
observed, but with different relative intensities. In all cases, the first chromatographic peak 220 
presented an abundant protonated molecule, whereas the second presented as peak base at 10 221 
eV with the product ion corresponding to the loss of NH3. This did not happen in GC–MS, 222 
where only one chromatographic peak was observed. This might be explained by the 223 
occurrence of rotamers. However, isolation and further spectroscopic experiments is needed to 224 
confirm and support this hypothesis. 225 
 226 
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Cannabinoids with a carbonyl link 227 
THJ-018 and THJ-2201 have similar structures, differing only in the absence and presence of 228 
a fluorine atom at the end of the chain, respectively. The main product ions were ion F, at m/z 229 
145.0402 (C8H5N2O), due to the carbonyl-indazole group, and ion B, which corresponded to 230 
the loss of the naphthalene group (C10H8) (Table 5). In the case of THJ-2201 (Fig. 6a), a 231 
subsequent loss of HF was also observed (ion C). (Figs. S.22-S.23).  232 
Other two cannabinoids were included in the same group, EG-018 (Fig. 6b) and BZ-233 
2201. They present similar fragmentation (Table 5), with the major product ions being m/z 234 
155.0497 (C11H7O, corresponding to the carbonyl-naphthalene group) and 127.0548 235 
(corresponding to the naphthalene group) (Figs S.24-S.25).  236 
 237 
Unidentified novel synthetic cannabinoids 238 
In addition to the SCs identified and discussed above, two samples contained unknown 239 
cannabinoids. After initial GC–MS experiments, their identification was not possible at the 240 
time of analysis. Therefore, subsequent analysis by LC–HR-MS was compulsory to elucidate 241 
the chemical structures of these compounds (for details see SM). 242 
The unidentified compound 1 was found in an herbal sample. After studying its 243 
fragmentation by both GC– EI-MS and LC–QTOF-MS(/MS) and taking into account the 244 
fragmentation observed for other cannabinoids, we suggest it to be F2201 (Fig. 7). This 245 
compound is not new actually (already administered as CAS 1391485-39-4), but it had never 246 
been seen on the drug market up to the moment of the analysis. 247 
GC–MS analysis of another herbal sample showed the presence of two compounds: 248 
SDB-006 and an unknown compound 2. After studying the MS/MS accurate-mass spectra 249 
obtained by LC–QTOF-MS(/MS) and comparing its fragmentation with that observed for the 250 
other cannabinoids, we suggest the compound to be dealkyl-SDB-006 (Fig. 8).  251 
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 252 
Third generation synthetic cannabinoids on the UK market detected during the overall 253 
study  254 
As most synthetic cannabinoids on the UK market were banned by the legislation coming into 255 
place in February 2013[13], it is not surprising that new SCs entered the UK market just before 256 
or mostly after the ban. As shown in the previous sections, a total of 25 cannabinoids (see Fig. 257 
1) plus two unknown compounds (third generation SCs), new to the UK market, were detected 258 
in this work. 259 
Three out of 25 compounds were found to be not previously reported cannabinoids and 260 
were identified in samples collected before the ban was in place (sampling period 1): 261 
APINACA (also known as AKB48), 5F-APINACA (5F-AKB48) and 5F-APICA (STS-135). 262 
These three compounds are closely related, because 5F-APINACA replaces a hydrogen atom 263 
by a fluoride atom in APINACA, and 5F-APICA is the indole analogue of 5F-APINACA.  264 
Three other non-reported cannabinoids were detected in the four months immediately 265 
after the ban (sampling period 2): BB-22, PB-22 and 5F-PB-22. Again, these compounds are 266 
closely related; as only the side chain was different; BB-22 has a methylcyclohexyl side chain, 267 
PB-22 a pentyl side chain, and 5F-PB-22 a 5-fluoropentyl side chain.  268 
Up to January 2015 (sampling period 3), a further 21 SCs, not previously reported in 269 
the UK market, were identified: 5F-Cumyl-PINACA, FUB-PB-22, 5F-NPB-22, EG-018, THJ-270 
018, THJ-2201, NM-2201, BZ-2201, F2201, SDB-006, dealkyl-SDB-006, 5F-MN-18, APICA, 271 
MDMB-CHMICA (also incorrectly known as MMB-CHMINACA), AB-CHMINACA, AB-272 
PINACA, 5F-AB-PINACA, ADB-PINACA, 5F-AMB, AB-FUBINACA and ADB-273 
FUBINACA. As it can be seen, some of these compounds were structurally-related to earlier 274 
found cannabinoids. For example, in 5F-Cumyl-PINACA, the adamantyl group of 5F-275 
APINACA is replaced by a cumyl group. FUB-PB-22 replaces the fluoropentyl chain of 5F-276 
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PB-22 with a para-fluorotoluene group. Two additional cannabinoids identified, EG-018, and 277 
SDB-006, were not related to the previously reported findings. Finally, the two compounds, 278 
not identified after initial GC–MS analysis, could be tentatively reported as F2201 and dealkyl-279 
SDB-006 in this study.  280 
It remains a question how effective the new legislation has been. Several compounds 281 
disappeared from the market, and as such, the ban already worked, but these products have 282 
been replaced rapidly by new compounds. However, the emergence of new compounds is not 283 
solely due the legislative change, as many new cannabinoids emerged on the UK market 284 
without new laws. Similar to what occurred in Japan, where new cannabinoids entered the 285 
market without a ban[14]. Other driving factors could be a legislative change elsewhere, 286 
commercial purposes and/or supply problems. In any case, it seems clear that rapid 287 
replacements exist in the market of SCs, with continuous appearance of new compounds, 288 
making their control troublesome for analytical laboratories. 289 
 290 
Sampling period immediately before and after the ban 291 
In the first sampling period, 49 samples were acquired between December 1st, 2012 and 292 
February 26th, 2013, when the date the new ban in the UK came into place. Another 54 samples 293 
were acquired in the second sampling period after the ban and before June 30th, 2013. Data 294 
obtained in the analysis of these 103 samples were used to evaluate the immediate effect of the 295 
ban on the market of SCs. Identification of the compounds found in all these samples was 296 
supported by the use of reference standards or known samples. Ten different SCs were 297 
identified in 87 samples, while the remaining 16 did not contain SCs. 298 
Before the ban, 88% of SCs found corresponded to compounds that were subsequently 299 
prohibited by the 2013 legislation. After the ban, 98% of the occurrences were of new (legal) 300 
SCs, i.e., compounds not controlled within the 2013 legislation. The only sample to contain a 301 
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banned substance after the prohibition was a powder labelled LY2183240, which contained 302 
UR-144 (Fig. 9). It is possible that the person selling this sample was simply stuck with the 303 
leftover UR-144 when the ban came into place, and decided to sell it as a non-controlled 304 
substance, thus still making money for an otherwise worthless amount of the SC. This would 305 
mean that the user is not aware that they are buying an illegal substance and is not informed as 306 
to what drug they are taking, putting them at more risk. According to these data, the change in 307 
legislation seemed to have the desired effect of clearing the market of the banned products. 308 
This is not a surprising observation, as SCs are sold as legal highs, and it is within the vendors’ 309 
interest not to sell illegal substances. This was also seen in a study by Kikura-Hanajiri et al. [14], 310 
who investigated the cannabinoid market in Japan following a change in legislation. 311 
When comparing the number of active ingredients per sample, there is a clear 312 
distinction to be made between powders (advertised as a pure compound) and herbal smoking 313 
mixtures. All the 16 powders analysed during this period contained one active ingredient. 314 
However, in herbal mixtures, the number of SCs that were present was variable. Before the 315 
ban, 33% of the herbal blends analysed did not contain any drugs, 45% contained one active 316 
ingredient, while 22% contained two SCs. After the ban, the great majority of samples (83%) 317 
contained only one active ingredient, while 15% contained no drugs; just 2% of the samples 318 
contained two SCs. It seems that immediately after the ban, manufacturers were using only one 319 
ingredient per sample. It might be due to a fear of mixing compounds that were relatively 320 
unknown for them. 321 
In this sampling round, several products with the same brand name were sampled more 322 
than once, because they came from a different source or from different times. The results 323 
showed that an important number of them changed ingredients and this was not always due to 324 
the change in legislation. Before the ban, three brands were sampled more than once, and for 325 
all of them, different compositions were found for the analyzed samples. “Mary Joy Evolution” 326 
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contained UR-144 and MAM2201 or only MAM2201; “Blue cheese” contained XLR11 or 327 
XLR11 and MAM2201; and “Abyss” contained either a mixture of UR-144 and MAM2201 or 328 
only MAM2201. Only one brand, “Doob” was available before and after the change in 329 
legislation. Before the ban, it contained AM2201 or a combination of AM2201 and UR-144. It 330 
is unclear why manufacturer decided to change the product, but it may be due to a supply 331 
problem with one of the ingredients or simply due to profit. However, the sample of “Doob” 332 
we obtained after the ban contained only 5F-APINACA, a different SC. As UR-144 and 333 
AM2201 were both banned, it is likely that the manufacturer switched to another SC. Changing 334 
of active ingredients can put users at risk as other ingredients may have different 335 
pharmacokinetic or dynamic properties.  336 
After the ban, four brands were sampled more than once and two of them did not change 337 
their ingredients, while two did. “Clockwork Orange” and “Chillem Blue” always contained 338 
5F-AKB48 as the only active ingredient, while “Dutchy” contained either 5F-AKB48 or 339 
AKB48 and “Magic Dragon” contained either 5F-AKB48 or 5F-PB-22. Hence, it seems that it 340 
was not only due to the ban that manufacturers decidde to switch to other ingredients.  341 
 342 
New physical forms for synthetic cannabinoids 343 
During the three sampling campaigns (December 2012-January 2015), most SCs found on the 344 
abuse market were sold as herbal smoking mixtures (i.e., dried herbs sprayed or mixed with 345 
SCs) or as powders. In the latter case, it is believed that the user mixes it with herbs before 346 
consumption. However, during this period, two other forms were found on the UK market. E-347 
cigarette refills (Fig. 10a) are meant to be loaded into an electronic cigarette; they are present 348 
as solutions in a volatile solvent, such as propylene glycol. However, the refill purchased from 349 
a UK website contained the SC, 5F-Cumyl-PINACA. It is unknown for us whether this method 350 
of drug consumption is less or more harmful than the traditional smoking of dried herbs. 351 
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Another form that was encountered was a resin-like material laced with SCs, such as “Squidgy” 352 
(Fig. 10b). This sample contained 5F-AB-PINACA. It is unclear what the resin itself is made 353 
of, but it seems to be marketed to resemble hashish (cannabis resin). 354 
 355 
  356 
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Conclusions 357 
In this work, we have surveyed the UK legal high market between December 2012 and January 358 
2015. Our results reveal that the legislative ban succeeded in pushing the corresponding 359 
compounds from the UK market, but only one of the banned compounds (UR-144) detected 360 
after the date when the ban came into place (February 26th, 2013). However, a risk of banning 361 
existing compounds is the emergence of new compounds (which as our result show, did 362 
happen), with unknown and potentially more dangerous effects. Another problem associated 363 
with banning compounds is the lack of information for both drug users and healthcare workers. 364 
Drug users do not know what they are taking after a ban, because branded products change 365 
ingredients or vendors mislabel products to be able to sell leftover stock. For healthcare and 366 
forensic professionals, there is little knowledge on new compounds, and they might be missed 367 
in drug screenings.  368 
In the face of the continuous changes in the products, it is necessary to reinforce 369 
analytical measurements for the monitoring of SCs to be able of efficiently detect and identify 370 
the new products that are substituting the already known compounds present in the market. 371 
Data presented for the third generation SCs in this work are useful not only for the monitoring 372 
of the SCs that we have found in the samples, but also to facilitate the detection and tentative 373 
identification of chemically-related compounds that share common product ions, which have 374 
been exemplified in tentative identification of unknown compound 1 and 2 to be F2201 and 375 
dealkyl-SDB-006, respectively, in this study. Product ion spectra for 27 SCs obtained from the 376 
third generation SC products using five different collision energies have been presented for 377 
such purpose. Such detailed data have not been reported to our knowledge. In addition, the 378 
appearance of two chromatographic (total ion current chromatograms or extracted ion 379 
chromatograms) peaks with a common octadecyl column appeared for AB-FUBINACA, ADB-380 
PINACA, AB-PINACA, 5F-AB-PINACA and AB- CHMINACA all with the presence of a 381 
18 
 
terminal amino group together with an enantiomeric carbon at the linker part merits mentioning 382 
again in this study. 383 
  384 
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TABLES 446 
Table 1 Product ions obtained by liquid chromatography – quadrupole time-of-flight- tandem mass spectrometry (LC–QTOF-MS/MS) for 447 
synthetic cannabinoids (SCs) with adamantyl amide groups, showing their exact mass and elemental compositions 448 
Compound A=[M+H]+ B C D E F RT 
APICA (2NE1) 
365.2564 
C24H33N2O 
214.1232 
C14H16NO 
135.1174 
C10H15 
107.0861 
C8H11 
93.0704 
C7H9 
79.0548 
C6H7 
14.9 
5F-APICA (STS-135) 
383.2499 
C24H32N2OF 
232.1138 
C14H15NOF 
135.1174 
C10H15 
107.0861 
C8H11 
93.0704 
C7H9 
79.0548 
C6H7 
14.1 
APINACA (AKB48) 
366.2545 
C23H32N3O 
 
135.1174 
C10H15 
107.0861 
C8H11 
93.0704 
C7H9 
79.0548 
C6H7 
15.5 
5F-APINACA (5F-
AKB48) 
384.2451 
C23H31N3OF 
 
135.1174 
C10H15 
107.0861 
C8H11 
93.0704 
C7H9 
79.0548 
C6H7 
14.5 
SDB-006 
321.1967 
C21H25N2O 
214.1232 
C14H16NO 
188.1439 
C13H18N 
144.0449 
C9H6NO 
132.0813 
C9H10N 
91.0548 
C7H7 
12.9 
RT retention time in minutes 449 
  450 
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Table 2. Product ions obtained by LC–QTOF-MS/MS for SCs with quinolyl esters, showing their exact mass and elemental compositions 451 
Compound A=[M+H]+ B C D E F G RT 
PB-22 
359.1770 
C23H23N2O2 
214.1232 
C14H16NO 
  
144.0449 
C9H6NO 
116.0500 
C8H6N 
 13.7 
5F-PB-22 
377.1665 
C23H22N2O2F 
232.1138 
C14H15NOF 
  
144.0449 
C9H6N 
116.0500 
C8H6N 
 12.5 
BB-22 
385.1916 
C25H25N2O2 
240.1388 
C16H18NO 
  
144.0449 
C9H6NO 
116.0500 
C8H6N 
 14.2 
NM-2201 
376.1711 
C24H23NO2F 
232.1138 
C14H15NOF 
  
144.0449 
C9H6NO 
116.0500 
C8H6N 
 14.1 
5F-NPB-22 
378.1618 
C22H21N3O2F 
233.1090 
C13H14N2OF 
213.1028 
C13H13N2O 
177.0453 
C12H5N2 
145.0402 
C8H5N2O 
117.0453 
C7H5N2 
90.0344 
C6H4N 
11.9 
5F-MN-18 
376.1825 
C23H22N3OF 
233.1090 
C13H14N2OF 
213.1028 
C13H13N2O 
177.0453 
C12H5N2 
145.0402 
C8H5N2O 
117.0453 
C7H5N2 
90.0344 
C6H4N 
13.4 
 452 
  453 
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Table 3 Product ions obtained by LC–QTOF-MS/MS for SCs with branched end groups, showing their exact mass and elemental 454 
compositions 455 
Compound A=[M+H]+ B C D E F G RT 
ADB-PINACAa 
345.2291 
C19H29N4O2 
328.2025 
C19H26N3O2 
300.2076 
C18H26N3O 
215.1184 
C13H15N2O 
  
145.0398 
C8H5N2O 
13.0 
AB-PINACAa 
331.2134 
C18H27N4O2 
314.1869 
C18H24N3O2 
286.1919 
C17H24N3O 
215.1184 
C13H15N2O 
  
145.0398 
C8H5N2O 
12.2 
5F-AB-PINACAa 
349.2040 
C18H26N4O2F 
332.1774 
C18H23N3O2F 
304.1825 
C17H23N3OF 
233.1090 
C13H14N2OF 
213.1028 
C13H13N2O 
177.0463 
C12H5N2 
145.0398 
C8H5N2O 
11.0 
5F-Cumyl-PINACA 
368.2138 
C22H27N3OF 
  
233.1090 
C13H14N2OF 
213.1028 
C13H13N2O 
177.0463 
C12H5N2 
145.0398 
C8H5N2O 
13.0 
AB-CHMINACAa 
357.2291 
C20H29N4O2 
340.2025 
C20H26N3O2 
312.2076 
C19H26N3O 
241.1341 
C15H17N2O 
  
145.0398 
C8H5N2O 
13.1 
MDMB-CHMICA 
385.2491 
C23H33N2O3 
  
240.1388 
C16H18NO 
  
144.0441 
C9H6NO 
14.1 
5F-AMB 
364.2036 
C19H27N3O3F 
332.1774 
C18H23N3O2F 
304.1825 
C17H23N3OF 
233.1090 
C13H14N2OF 
213.1028 
C13H13N2O 
177.0463 
C12H5N2 
145.0398 
C8H5N2O 
12.1 
a Two chromatographic peaks were observed in the LC–QTOF-MS chromatogram for these compounds. Only the product ions for the most 456 
intense one are shown. For additional details, see supplementary material (SM)   457 
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Table 4 Product ions obtained by LC–QTOF-MS/MS for SCs with a para-fluorotoluene group, showing their exact mass and elemental 458 
compositions 459 
Compound A=[M+H]+ B C D E RT 
AB-FUBINACAa 
369.1727 
C20H22N4O2F 
352.1461 
C20H19N3O2F 
324.1512 
C19H19N3OF 
253.0777 
C15H10N2OF 
109.0454 
C7H6F 
11.5 
ADB-FUBINACA 
383.1883 
C21H24N4O2F 
366.1618 
C21H21N3O2F 
338.1669 
C20H21N3OF 
253.0777 
C15H10N2OF 
109.0454 
C7H6F 
11.9 
FUB-PB-22 
397.1352 
C25H18N2O2F 
  
252.0825 
C16H11NOF 
109.0454 
C7H6F 
12.9 
a Two chromatographic peaks were observed in the UPLC-QTOF MS chromatogram for these compounds. Only the product ions for the 460 
most intense one are shown. For additional details, see SM 461 
  462 
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Table 5 Product ions obtained by LC–QTOF-MS/MS for SCs with a carbonyl link, showing their exact mass and elemental compositions  463 
Compound A=[M+H]+ B C D E F G H I RT 
THJ-018 
343.18109 
C23H23N2O 
215.1184 
C13H15N2O 
  
 145.0402 
C8H5N2O 
127.0548 
C10H7 
117.0453 
C7H5N2 
90.0344 
C6H4N 
14.7 
THJ-2201 
361.1716 
C23H22N2OF 
233.1090 
C13H14N2OF 
213.1028 
C13H13N2O 
 
177.0453 
C12H5N2 
145.0402 
C8H5N2O 
127.0548 
C10H7 
117.0453 
C7H5N2 
90.0344 
C6H4N 
13.6 
BZ-2201 
361.1716 
C23H22N2OF 
233.1090 
C13H14N2OF 
 
155.0497 
C11H7O 
177.0453 
C12H5N2 
145.0402 
C8H5N2O 
127.0548 
C10H7 
117.0453 
C7H5N2 
90.0344 
C6H4N 
13.2 
EG-018 
392.2014 
C28H26NO 
  
155.0497 
C11H7O 
 145.0402 
C8H5N2O 
127.0548 
C10H7 
  15.8 
464 
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FIGURE CAPTIONS 466 
Fig. 1 Structures of synthetic cannabinoids (SCs) classified according to the structure and 467 
fragmentation  468 
Fig. 2 Liquid chromatography – quadrupole time-of-flight-tandem mass spectrometry (LC–469 
QTOF-MS/MS) spectra of a APICA and b SDB-006, at different collision energies with 470 
product ions identified together with the probable fragmentation modes 471 
Fig. 3 LC–QTOF-MS/MS spectra of a PB-22 and b 5F-NPB-22, at different collision energies 472 
with product ions identified together with the probable fragmentation modes 473 
Fig. 4 LC–QTOF-MS/MS spectra of a ADB-PINACA and b 5F-AB-PINACA, at different 474 
collision energies with product ions identified together with the probable fragmentation 475 
modes 476 
Fig. 5 a Total ion current chromatographic peaks obtained for AB-FUBINACA by LC–QTOF-477 
MS and b, c MS/MS spectra obtained for each chromatographic peak at different 478 
collision energies with product ions identified  479 
Fig. 6 LC–QTOF-MS/MS spectra of a THJ-2201 and b EG-018, at different collision energies 480 
with product ions identified together with the probable fragmentation modes 481 
Fig. 7 Tentative identification of unidentified compound 1. a Gas chromatography – mass 482 
spectrometry spectra, and b LC–QTOF-MS/MS spectra at different collision energies  483 
Fig. 8 LC–QTOF-MS/MS spectra at different collision energies for unidentified compound 2 484 
Fig. 9 Compounds found in sampling campaigns between December 2012 and June 2013 485 
(sampling periods 1 and 2) showing the SC profiles before and after the 2013 legislation 486 
in the UK 487 
Fig. 10 a A product sold as an e-cigarette refill, and b a product sold as a resin  488 
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SC with adamantyl amide group 
 
SC with quinolyl esters 
 
SC with a para-fluorotoluene chain 
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PB-22 C Pentyl O N 
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methylpropyl 
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 (STS-135) 
C 5-Fluoropentyl Adamantyl  5F-PB-22 C 5-Fluoropentyl O N 
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N Pentyl Adamantyl  BB-22 C  
Cyclohexylmethyl 
O N 
FUB-PB-22 C 
 
8-Quinolinol,  
 this group replaces NH-R2 
5F-APINACA 
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N 5-Fluoropentyl Adamantyl  NM-2201 C 5-Fluoropentyl O C 
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SC with branched end groups 
 
SC with a carbonyl link 
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Fig. 9 522 
  523 
0
10
20
30
40
50
%
 o
f 
o
cc
u
re
n
ce
s
Under new ban                 Not controlled by new ban
Before 2013 ban was in place
After 2013 ban was in place
39 
 
 524 
  
a b 
 525 
Fig. 10 526 
